🔴 Beam Therapeutics is trading 4.5% down today as elevated Treasury yields pressure growth valuations

Beam Therapeutics is trading now at $28.41 (-4.54%) amid broader risk-off pressure on growth stocks.

• The Nasdaq Composite is down 0.53%, while elevated Treasury yields continue pressuring growth valuations.
• Investors are weighing Iran sanctions threats, failed U.S.-Canada trade talks, Nvidia earnings, and Jackson Hole positioning; Reuters reported elevated long-term yields and geopolitical uncertainty affecting markets on August 24, 2026.
• No new company-specific announcement, regulatory action, or analyst move was identified for August 24, 2026; the latest major company update was August 4 earnings and pipeline news.